BioXcel Therapeutics, Inc. financial statements
BioXcel Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 642K | 10-K |
| Net income | −USD 69.9M | 10-K |
| Cash and equivalents | USD 28.41M | 10-Q |
| Total debt | USD 109.59M | 10-Q |
BioXcel Therapeutics, Inc. financials on 6ix · BioXcel Therapeutics, Inc. on 6ix